{"parse":{"title":"Investigational New Drug","pageid":1487123,"revid":858045891,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"vertical-navbox nowraplinks\" style=\"float:right;clear:right;width:22.0em;margin:0 0 1.0em 1.0em;background:#f9f9f9;border:1px solid #aaa;padding:0.2em;border-spacing:0.4em 0;text-align:center;line-height:1.4em;font-size:88%\"><tbody><tr><th style=\"padding:0.2em 0.4em 0.2em;font-size:145%;line-height:1.2em\">Regulation of therapeutic goods in the United States</th></tr><tr><td style=\"padding:0.2em 0 0.4em\"><a href=\"/wiki/File:Ritalin-SR-20mg-1000x1000.jpg\" class=\"image\"><img alt=\"Ritalin-SR-20mg-1000x1000.jpg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a9/Ritalin-SR-20mg-1000x1000.jpg/220px-Ritalin-SR-20mg-1000x1000.jpg\" width=\"220\" height=\"220\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a9/Ritalin-SR-20mg-1000x1000.jpg/330px-Ritalin-SR-20mg-1000x1000.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a9/Ritalin-SR-20mg-1000x1000.jpg/440px-Ritalin-SR-20mg-1000x1000.jpg 2x\" data-file-width=\"1168\" data-file-height=\"1168\" /></a></td></tr><tr><td style=\"padding:0 0.1em 0.4em\">\n<a href=\"/wiki/Prescription_drugs\" class=\"mw-redirect\" title=\"Prescription drugs\">Prescription drugs</a> <br /> <a href=\"/wiki/Over-the-counter_drugs\" class=\"mw-redirect\" title=\"Over-the-counter drugs\">Over-the-counter drugs</a></td>\n</tr><tr><td style=\"padding:0 0.1em 0.4em\">\n<div class=\"NavFrame collapsed\" style=\"border:none;padding:0\"><div class=\"NavHead\" style=\"font-size:105%;background:transparent;text-align:left\">Law</div><div class=\"NavContent\" style=\"font-size:105%;padding:0.2em 0 0.4em;text-align:center\"><a href=\"/wiki/Federal_Food,_Drug,_and_Cosmetic_Act\" title=\"Federal Food, Drug, and Cosmetic Act\">Federal Food, Drug, and Cosmetic Act</a><br /><a href=\"/wiki/Comprehensive_Drug_Abuse_Prevention_and_Control_Act_of_1970\" title=\"Comprehensive Drug Abuse Prevention and Control Act of 1970\">Comprehensive Drug Abuse Prevention and Control Act of 1970</a><br /><a href=\"/wiki/Controlled_Substances_Act\" title=\"Controlled Substances Act\">Controlled Substances Act</a><br /><a href=\"/wiki/Prescription_Drug_Marketing_Act\" title=\"Prescription Drug Marketing Act\">Prescription Drug Marketing Act</a><br /><a href=\"/wiki/Drug_Price_Competition_and_Patent_Term_Restoration_Act\" title=\"Drug Price Competition and Patent Term Restoration Act\">Drug Price Competition and Patent Term Restoration Act</a><br /><a href=\"/wiki/Hatch-Waxman_exemption\" class=\"mw-redirect\" title=\"Hatch-Waxman exemption\">Hatch-Waxman exemption</a><br /><a href=\"/wiki/Marihuana_Tax_Act\" class=\"mw-redirect\" title=\"Marihuana Tax Act\">Marihuana Tax Act</a></div></div></td>\n</tr><tr><td style=\"padding:0 0.1em 0.4em\">\n<div class=\"NavFrame collapsed\" style=\"border:none;padding:0\"><div class=\"NavHead\" style=\"font-size:105%;background:transparent;text-align:left\">Government agencies</div><div class=\"NavContent\" style=\"font-size:105%;padding:0.2em 0 0.4em;text-align:center\"><a href=\"/wiki/United_States_Department_of_Health_and_Human_Services\" title=\"United States Department of Health and Human Services\">Department of Health and Human Services</a><br /><a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a><br /><a href=\"/wiki/United_States_Department_of_Justice\" title=\"United States Department of Justice\">Department of Justice</a><br /><a href=\"/wiki/Drug_Enforcement_Administration\" title=\"Drug Enforcement Administration\">Drug Enforcement Administration</a></div></div></td>\n</tr><tr><td style=\"padding:0 0.1em 0.4em\">\n<div class=\"NavFrame collapsed\" style=\"border:none;padding:0\"><div class=\"NavHead\" style=\"font-size:105%;background:transparent;text-align:left\">Process</div><div class=\"NavContent\" style=\"font-size:105%;padding:0.2em 0 0.4em;text-align:center\"><a href=\"/wiki/Drug_discovery\" title=\"Drug discovery\">Drug discovery</a><br /><a href=\"/wiki/Drug_design\" title=\"Drug design\">Drug design</a><br /><a href=\"/wiki/Drug_development\" title=\"Drug development\">Drug development</a><br /><a href=\"/wiki/New_drug_application\" class=\"mw-redirect\" title=\"New drug application\">New drug application</a><br /><a href=\"/wiki/Investigational_new_drug\" class=\"mw-redirect\" title=\"Investigational new drug\">Investigational new drug</a><br /><a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">Clinical trial</a> (Phase I, II, III, IV)<br /><a href=\"/wiki/Randomized_controlled_trial\" title=\"Randomized controlled trial\">Randomized controlled trial</a><br /><a href=\"/wiki/Pharmacovigilance\" title=\"Pharmacovigilance\">Pharmacovigilance</a><br /><a href=\"/wiki/Abbreviated_New_Drug_Application\" title=\"Abbreviated New Drug Application\">Abbreviated New Drug Application</a><br /><a href=\"/wiki/FDA_Fast_Track_Development_Program\" class=\"mw-redirect\" title=\"FDA Fast Track Development Program\">Fast track approval</a><br /><a href=\"/wiki/Off-label_use\" title=\"Off-label use\">Off-label use</a></div></div></td>\n</tr><tr><td style=\"padding:0 0.1em 0.4em\">\n<div class=\"NavFrame collapsed\" style=\"border:none;padding:0\"><div class=\"NavHead\" style=\"font-size:105%;background:transparent;text-align:left\">International coordination</div><div class=\"NavContent\" style=\"font-size:105%;padding:0.2em 0 0.4em;text-align:center\"><a href=\"/wiki/International_Conference_on_Harmonisation_of_Technical_Requirements_for_Registration_of_Pharmaceuticals_for_Human_Use\" class=\"mw-redirect\" title=\"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use\">International Conference on Harmonisation of Technical<br />Requirements for Registration of Pharmaceuticals for Human Use</a><br /><a href=\"/wiki/Uppsala_Monitoring_Centre\" title=\"Uppsala Monitoring Centre\">Uppsala Monitoring Centre</a><br /><a href=\"/wiki/World_Health_Organization\" title=\"World Health Organization\">World Health Organization</a><br /><a href=\"/wiki/Council_for_International_Organizations_of_Medical_Sciences\" title=\"Council for International Organizations of Medical Sciences\">Council for International Organizations of Medical Sciences</a><br /><a href=\"/wiki/Single_Convention_on_Narcotic_Drugs\" title=\"Single Convention on Narcotic Drugs\">Single Convention on Narcotic Drugs</a></div></div></td>\n</tr><tr><td style=\"padding:0 0.1em 0.4em\">\n<div class=\"NavFrame collapsed\" style=\"border:none;padding:0\"><div class=\"NavHead\" style=\"font-size:105%;background:transparent;text-align:left;padding-right:2em;background:transparent;text-align:left;\">Non-governmental organizations</div><div class=\"NavContent\" style=\"font-size:105%;padding:0.2em 0 0.4em;text-align:center\"><a href=\"/wiki/Institute_of_Medicine\" class=\"mw-redirect\" title=\"Institute of Medicine\">Institute of Medicine</a><br /><a href=\"/wiki/Research_on_Adverse_Drug_events_And_Reports\" class=\"mw-redirect\" title=\"Research on Adverse Drug events And Reports\">Research on Adverse Drug events And Reports</a><br /><a href=\"/wiki/NORML\" class=\"mw-redirect\" title=\"NORML\">NORML</a></div></div></td>\n</tr><tr><td style=\"text-align:right;font-size:115%;padding-top: 0.6em;\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Regulation_of_therapeutic_goods_in_the_United_States\" title=\"Template:Regulation of therapeutic goods in the United States\"><abbr title=\"View this template\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Regulation_of_therapeutic_goods_in_the_United_States\" title=\"Template talk:Regulation of therapeutic goods in the United States\"><abbr title=\"Discuss this template\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Regulation_of_therapeutic_goods_in_the_United_States&amp;action=edit\"><abbr title=\"Edit this template\">e</abbr></a></li></ul></div></td></tr></tbody></table>\n<p>The United States <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a>'s <b>Investigational New Drug (IND)</b> program is the means by which a <a href=\"/wiki/Pharmaceutical_industry\" title=\"Pharmaceutical industry\">pharmaceutical company</a> obtains permission to start human clinical trials and to ship an experimental drug <a href=\"/wiki/Interstate_commerce\" class=\"mw-redirect\" title=\"Interstate commerce\">across state lines</a> (usually to clinical investigators) before a marketing application for the drug has been approved. Regulations are primarily at <span><a href=\"/wiki/Title_21_of_the_Code_of_Federal_Regulations\" title=\"Title 21 of the Code of Federal Regulations\">21 C.F.R.</a>&#32;<a rel=\"nofollow\" class=\"external text\" href=\"https://www.law.cornell.edu/cfr/text/21/312\">312</a></span>. Similar procedures are followed in the European Union, Japan, and Canada.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Types\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Types</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Application\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Application</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Miscellaneous\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Miscellaneous</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Examples\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Examples</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#See_also\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#References\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-7\"><a href=\"#External_links\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Types\">Types</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Investigational_New_Drug&amp;action=edit&amp;section=1\" title=\"Edit section: Types\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Drug_Evaluation_Process.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/8/87/Drug_Evaluation_Process.jpg/220px-Drug_Evaluation_Process.jpg\" width=\"220\" height=\"78\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/8/87/Drug_Evaluation_Process.jpg/330px-Drug_Evaluation_Process.jpg 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/87/Drug_Evaluation_Process.jpg/440px-Drug_Evaluation_Process.jpg 2x\" data-file-width=\"1433\" data-file-height=\"507\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Drug_Evaluation_Process.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>Timeline for drug evaluation</div></div></div>\n<ul><li><b>Commercial INDs</b> are filed by companies to obtain marketing approval for a new drug.</li>\n<li><b>Research or Investigator INDs</b> are non-commercial INDs filed by researchers to study an unapproved drug or to study an approved drug for a new indication or in a new patient population.</li>\n<li><b><a href=\"/wiki/Expanded_access\" title=\"Expanded access\">Emergency Use INDs</a></b>, also called compassionate use or single-patient INDs, are filed for emergency use of an unapproved drug when the clinical situation does not allow sufficient time to submit an IND in accordance with 21 CFR \u00a7\u00a7 312.23, 312.24. These are most commonly used for life-threatening conditions for which there is no standard treatment.</li>\n<li><b><a href=\"/wiki/Expanded_access\" title=\"Expanded access\">Treatment INDs</a></b> are filed to make a drug available for treatment of serious or immediately life-threatening conditions prior to FDA approval. Serious diseases or conditions are stroke, schizophrenia, rheumatoid arthritis, osteoarthritis, chronic depression, seizures, Alzheimer's dementia, amyotrophic lateral sclerosis (ALS), and narcolepsy.</li>\n<li><b>Screening INDs</b> are filed for multiple, closely related compounds in order to screen for the preferred compounds or formulations. The preferred compound can then be developed under a separate IND. Used for screening different salts, esters and other drug derivatives that are chemically different, but pharmacodynamically similar.</li></ul>\n<h2><span class=\"mw-headline\" id=\"Application\">Application</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Investigational_New_Drug&amp;action=edit&amp;section=2\" title=\"Edit section: Application\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The IND application may be divided into the following categories:<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup>\n</p>\n<ol><li><b>Preclinical Testing</b> consists of animal pharmacology and toxicology studies to assess whether the drug is safe for testing in humans. Also included are any previous experience with the drug in humans (often foreign use).</li>\n<li><b>Manufacturing Information</b> includes composition, manufacturer, and stability of, and the controls used for, manufacturing the drug. Used to ensure that the company can adequately produce and supply consistent batches of the drug.</li>\n<li><b>Investigator Information</b> on the qualifications of clinical investigators, that is, the professionals (generally physicians) who oversee the administration of the experimental drug to the study subjects. Used to assess whether the investigators are qualified to fulfill their clinical trial duties.</li>\n<li><b><a href=\"/wiki/Clinical_trial_protocol\" class=\"mw-redirect\" title=\"Clinical trial protocol\">Clinical Trial Protocols</a></b> are the centerpiece of the IND. Detailed protocols for proposed clinical studies to assess whether the initial-phase trials will expose the subjects to unnecessary risks.</li>\n<li><b>Other Commitments</b> are commitments to obtain <a href=\"/wiki/Informed_consent\" title=\"Informed consent\">informed consent</a> from the research subjects, to obtain review of the study by an <a href=\"/wiki/Institutional_review_board\" title=\"Institutional review board\">institutional review board</a> (IRB), and to adhere to the investigational new drug regulations.</li></ol>\n<p>An IND must also include an <i><a href=\"/wiki/Investigator%27s_Brochure\" class=\"mw-redirect\" title=\"Investigator&#39;s Brochure\">Investigator's Brochure</a></i> intended to educate the trial investigators of the significant facts about the trial drug they need to know to conduct their clinical trial with the least hazard to the subjects or patients.\n</p><p>Once an IND is submitted, the FDA has 30 days to object to the IND or it automatically becomes effective and <a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">clinical trials</a> may begin. If the FDA detects a problem, it may place a clinical hold on the IND, prohibiting the start of the clinical studies until the problem is resolved. \n</p><p>Experimental drugs under an IND must be labeled \"Caution: New Drug \u2013 Limited by Federal (or United States) law to investigational use.\"\n</p>\n<h2><span class=\"mw-headline\" id=\"Miscellaneous\">Miscellaneous</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Investigational_New_Drug&amp;action=edit&amp;section=3\" title=\"Edit section: Miscellaneous\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Approximately two thirds of both investigational new drugs (INDs) and <a href=\"/wiki/New_drug_application\" class=\"mw-redirect\" title=\"New drug application\">new drug applications</a> (NDAs) are <a href=\"/wiki/Small-molecule_drug\" class=\"mw-redirect\" title=\"Small-molecule drug\">small-molecule drugs</a>, the rest are <a href=\"/wiki/Biopharmaceutical\" title=\"Biopharmaceutical\">biopharmaceuticals</a>. About half of the investigational new drugs (INDs) fail in preclinical and clinical phases of drug development.\n</p>\n<h2><span class=\"mw-headline\" id=\"Examples\">Examples</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Investigational_New_Drug&amp;action=edit&amp;section=4\" title=\"Edit section: Examples\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The FDA runs a <a href=\"/wiki/Medical_marijuana\" class=\"mw-redirect\" title=\"Medical marijuana\">medical marijuana</a> IND program (the <a href=\"/wiki/Compassionate_Investigational_New_Drug_program\" class=\"mw-redirect\" title=\"Compassionate Investigational New Drug program\">Compassionate Investigational New Drug program</a>).  It stopped accepting new patients in 1992 after public health authorities concluded there was no scientific value to it, and due to President <a href=\"/wiki/George_H.W._Bush\" class=\"mw-redirect\" title=\"George H.W. Bush\">George H.W. Bush</a> administration's desire to \"get tough on crime and drugs.\"  As of 2011, four patients continue to receive <a href=\"/wiki/Cannabis_(drug)\" title=\"Cannabis (drug)\">cannabis</a> from the government under the program.<sup id=\"cite_ref-4_Americans_get_medical_pot_from_the_feds_2-0\" class=\"reference\"><a href=\"#cite_note-4_Americans_get_medical_pot_from_the_feds-2\">&#91;2&#93;</a></sup>\n</p><p>Sanctioned by <a href=\"/wiki/Executive_Order_13139\" title=\"Executive Order 13139\">Executive Order 13139</a>, the <a href=\"/wiki/US_Department_of_Defense\" class=\"mw-redirect\" title=\"US Department of Defense\">US Department of Defense</a> employed an <a href=\"/wiki/Anthrax_vaccine\" class=\"mw-redirect\" title=\"Anthrax vaccine\">anthrax vaccine</a> classified as an investigational new drug (IND) in its <a href=\"/wiki/Anthrax_Vaccine_Immunization_Program\" title=\"Anthrax Vaccine Immunization Program\">Anthrax Vaccine Immunization Program</a> (AVIP).\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Investigational_New_Drug&amp;action=edit&amp;section=5\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Abigail_Alliance_for_Better_Access_to_Developmental_Drugs\" class=\"mw-redirect\" title=\"Abigail Alliance for Better Access to Developmental Drugs\">Abigail Alliance for Better Access to Developmental Drugs</a></li>\n<li><a href=\"/wiki/Drug_Discovery\" class=\"mw-redirect\" title=\"Drug Discovery\">Drug Discovery</a></li>\n<li><a href=\"/wiki/FDA_Fast_Track_Development_Program\" class=\"mw-redirect\" title=\"FDA Fast Track Development Program\">FDA Fast Track Development Program</a></li>\n<li><a href=\"/wiki/Good_Manufacturing_Practice\" class=\"mw-redirect\" title=\"Good Manufacturing Practice\">Good Manufacturing Practice</a></li>\n<li><a href=\"/wiki/Inverse_benefit_law\" title=\"Inverse benefit law\">Inverse benefit law</a></li>\n<li><a href=\"/wiki/New_drug_application\" class=\"mw-redirect\" title=\"New drug application\">New drug application</a>, after clinical trials</li>\n<li><a href=\"/wiki/Biologics_license_application\" title=\"Biologics license application\">Biologics license application</a></li>\n<li><a href=\"/wiki/Orphan_drug\" title=\"Orphan drug\">Orphan drug</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Investigational_New_Drug&amp;action=edit&amp;section=6\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"mw-references-wrap\"><ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFJohn_S._McInnes2011\" class=\"citation\">John S. McInnes (2011), \"New Drug Applications\",  in Shayne C. Gad, <i>Pharmaceutical Sciences Encyclopedia</i>, <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/9780470571224.pse420\">10.1002/9780470571224.pse420</a></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=New+Drug+Applications&amp;rft.btitle=Pharmaceutical+Sciences+Encyclopedia&amp;rft.date=2011&amp;rft_id=info%3Adoi%2F10.1002%2F9780470571224.pse420&amp;rft.au=John+S.+McInnes&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AInvestigational+New+Drug\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4_Americans_get_medical_pot_from_the_feds-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4_Americans_get_medical_pot_from_the_feds_2-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.cbsnews.com/news/4-americans-get-medical-pot-from-the-feds/\">\"4 Americans get medical pot from the feds\"</a>. <i><a href=\"/wiki/CBS_News\" title=\"CBS News\">CBS News</a></i>. September 28, 2011.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CBS+News&amp;rft.atitle=4+Americans+get+medical+pot+from+the+feds&amp;rft.date=2011-09-28&amp;rft_id=http%3A%2F%2Fwww.cbsnews.com%2Fnews%2F4-americans-get-medical-pot-from-the-feds%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AInvestigational+New+Drug\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Investigational_New_Drug&amp;action=edit&amp;section=7\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/cder/regulatory/applications/ind_page_1.htm\">Investigational New Drug (IND) Application Process</a> Center for Drug Evaluation and Research, Food and Drug Administration.</li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/cder/guidance/959fnl.pdf\">ICH Guidance for Industry, E6 Good Clinical Practice: Consolidated Guidance. BROKEN LINK</a></li>\n<li>Troetel, W.M.:  Achieving a Successful US IND Filing (1)  The Regulatory Affairs Journal. 6: 22\u201328, January 1995.</li>\n<li>Troetel, W.M.:  Achieving a Successful US IND Filing (2)  The Regulatory Affairs Journal. 6: 104\u2013108, February 1995.</li>\n<li><cite class=\"citation encyclopaedia\"><a href=\"/wiki/Daniel_Henninger\" title=\"Daniel Henninger\">Henninger, Daniel</a> (2002). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.econlib.org/library/Enc1/DrugLag.html\">\"Drug Lag\"</a>.  In <a href=\"/wiki/David_R._Henderson\" title=\"David R. Henderson\">David R. Henderson</a> (ed.). <i><a href=\"/wiki/Concise_Encyclopedia_of_Economics\" class=\"mw-redirect\" title=\"Concise Encyclopedia of Economics\">Concise Encyclopedia of Economics</a></i> (1st ed.). <a href=\"/wiki/Library_of_Economics_and_Liberty\" class=\"mw-redirect\" title=\"Library of Economics and Liberty\">Library of Economics and Liberty</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Drug+Lag&amp;rft.btitle=Concise+Encyclopedia+of+Economics&amp;rft.edition=1st&amp;rft.pub=Library+of+Economics+and+Liberty&amp;rft.date=2002&amp;rft.aulast=Henninger&amp;rft.aufirst=Daniel&amp;rft_id=http%3A%2F%2Fwww.econlib.org%2Flibrary%2FEnc1%2FDrugLag.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AInvestigational+New+Drug\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span class=\"citation-comment\" style=\"display:none; color:#33aa33; margin-left:0.3em\">CS1 maint: Extra text: editors list (<a href=\"/wiki/Category:CS1_maint:_Extra_text:_editors_list\" title=\"Category:CS1 maint: Extra text: editors list\">link</a>) </span> <a href=\"/wiki/OCLC\" title=\"OCLC\">OCLC</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://www.worldcat.org/oclc/317650570\">317650570</a>,&#32;<a rel=\"nofollow\" class=\"external text\" href=\"https://www.worldcat.org/oclc/50016270\">50016270</a>,&#32;<a rel=\"nofollow\" class=\"external text\" href=\"https://www.worldcat.org/oclc/163149563\">163149563</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/InvestigationalNewDrugINDApplication/ucm071073.htm\">IND Forms and Instructions</a> from the US <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a></li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw1319\nCached time: 20180904183924\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.132 seconds\nReal time usage: 0.158 seconds\nPreprocessor visited node count: 464/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 19262/2097152 bytes\nTemplate argument size: 420/2097152 bytes\nHighest expansion depth: 11/40\nExpensive parser function count: 2/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 2105/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.053/10.000 seconds\nLua memory usage: 1.9 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  122.543      1 -total\n 40.92%   50.143      1 Template:Citation\n 26.05%   31.920      1 Template:Regulation_of_therapeutic_goods_in_the_United_States\n 23.61%   28.934      1 Template:Sidebar_with_collapsible_lists\n  8.08%    9.907      1 Template:OCLC\n  7.01%    8.594      1 Template:Cite_news\n  6.53%    7.998      1 Template:Catalog_lookup_link\n  6.34%    7.764      1 Template:Cite_encyclopedia\n  5.37%    6.581      1 Template:USCFR\n  1.96%    2.407     12 Template:Trim\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:1487123-0!canonical and timestamp 20180904183924 and revision id 858045891\n -->\n</div>"},"langlinks":[{"lang":"ar","url":"https://ar.wikipedia.org/wiki/%D8%AF%D9%88%D8%A7%D8%A1_%D8%AA%D8%AC%D8%B1%D9%8A%D8%A8%D9%8A_%D8%AC%D8%AF%D9%8A%D8%AF","langname":"Arabic","autonym":"\u0627\u0644\u0639\u0631\u0628\u064a\u0629","*":"\u062f\u0648\u0627\u0621 \u062a\u062c\u0631\u064a\u0628\u064a \u062c\u062f\u064a\u062f"},{"lang":"es","url":"https://es.wikipedia.org/wiki/Investigational_New_Drug","langname":"Spanish","autonym":"espa\u00f1ol","*":"Investigational New Drug"}],"categories":[{"sortkey":"","hidden":"","*":"CS1_maint:_Extra_text:_editors_list"},{"sortkey":"","*":"Clinical_research"},{"sortkey":"","*":"Food_and_Drug_Administration"},{"sortkey":"","*":"Drug_safety"}],"links":[{"ns":0,"*":"Title 21 CFR Part 312"},{"ns":0,"exists":"","*":"Title 21 of the Code of Federal Regulations"},{"ns":0,"exists":"","*":"Abbreviated New Drug Application"},{"ns":0,"exists":"","*":"Abigail Alliance for Better Access to Developmental Drugs"},{"ns":0,"exists":"","*":"Anthrax Vaccine Immunization Program"},{"ns":0,"exists":"","*":"Anthrax vaccine"},{"ns":0,"exists":"","*":"Biologics license application"},{"ns":0,"exists":"","*":"Biopharmaceutical"},{"ns":0,"exists":"","*":"CBS News"},{"ns":0,"exists":"","*":"Cannabis (drug)"},{"ns":0,"exists":"","*":"Clinical trial"},{"ns":0,"exists":"","*":"Clinical trial protocol"},{"ns":0,"exists":"","*":"Compassionate Investigational New Drug program"},{"ns":0,"exists":"","*":"Comprehensive Drug Abuse Prevention and Control Act of 1970"},{"ns":0,"exists":"","*":"Concise Encyclopedia of Economics"},{"ns":0,"exists":"","*":"Controlled Substances Act"},{"ns":0,"exists":"","*":"Council for International Organizations of Medical Sciences"},{"ns":0,"exists":"","*":"Daniel Henninger"},{"ns":0,"exists":"","*":"David R. Henderson"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Drug Discovery"},{"ns":0,"exists":"","*":"Drug Enforcement Administration"},{"ns":0,"exists":"","*":"Drug Price Competition and Patent Term Restoration Act"},{"ns":0,"exists":"","*":"Drug design"},{"ns":0,"exists":"","*":"Drug development"},{"ns":0,"exists":"","*":"Drug discovery"},{"ns":0,"exists":"","*":"Executive Order 13139"},{"ns":0,"exists":"","*":"Expanded access"},{"ns":0,"exists":"","*":"FDA Fast Track Development Program"},{"ns":0,"exists":"","*":"Federal Food, Drug, and Cosmetic Act"},{"ns":0,"exists":"","*":"Food and Drug Administration"},{"ns":0,"exists":"","*":"George H.W. Bush"},{"ns":0,"exists":"","*":"Good Manufacturing Practice"},{"ns":0,"exists":"","*":"Hatch-Waxman exemption"},{"ns":0,"exists":"","*":"Informed consent"},{"ns":0,"exists":"","*":"Institute of Medicine"},{"ns":0,"exists":"","*":"Institutional review board"},{"ns":0,"exists":"","*":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use"},{"ns":0,"exists":"","*":"Interstate commerce"},{"ns":0,"exists":"","*":"Inverse benefit law"},{"ns":0,"exists":"","*":"Investigational new drug"},{"ns":0,"exists":"","*":"Investigator's Brochure"},{"ns":0,"exists":"","*":"Library of Economics and Liberty"},{"ns":0,"exists":"","*":"Marihuana Tax Act"},{"ns":0,"exists":"","*":"Medical marijuana"},{"ns":0,"exists":"","*":"NORML"},{"ns":0,"exists":"","*":"New drug application"},{"ns":0,"exists":"","*":"OCLC"},{"ns":0,"exists":"","*":"Off-label use"},{"ns":0,"exists":"","*":"Orphan drug"},{"ns":0,"exists":"","*":"Over-the-counter drugs"},{"ns":0,"exists":"","*":"Pharmaceutical industry"},{"ns":0,"exists":"","*":"Pharmacovigilance"},{"ns":0,"exists":"","*":"Prescription Drug Marketing Act"},{"ns":0,"exists":"","*":"Prescription drugs"},{"ns":0,"exists":"","*":"Randomized controlled trial"},{"ns":0,"exists":"","*":"Research on Adverse Drug events And Reports"},{"ns":0,"exists":"","*":"Single Convention on Narcotic Drugs"},{"ns":0,"exists":"","*":"Small-molecule drug"},{"ns":0,"exists":"","*":"US Department of Defense"},{"ns":0,"exists":"","*":"United States Department of Health and Human Services"},{"ns":0,"exists":"","*":"United States Department of Justice"},{"ns":0,"exists":"","*":"Uppsala Monitoring Centre"},{"ns":0,"exists":"","*":"World Health Organization"},{"ns":10,"exists":"","*":"Template:Regulation of therapeutic goods in the United States"},{"ns":11,"exists":"","*":"Template talk:Regulation of therapeutic goods in the United States"},{"ns":14,"exists":"","*":"Category:CS1 maint: Extra text: editors list"}],"templates":[{"ns":10,"exists":"","*":"Template:Regulation of therapeutic goods in the United States"},{"ns":10,"exists":"","*":"Template:Sidebar with collapsible lists"},{"ns":10,"exists":"","*":"Template:USCFR"},{"ns":10,"exists":"","*":"Template:CodeFedReg"},{"ns":10,"exists":"","*":"Template:Citation"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Cite encyclopedia"},{"ns":10,"exists":"","*":"Template:OCLC"},{"ns":10,"exists":"","*":"Template:Catalog lookup link"},{"ns":10,"exists":"","*":"Template:Trim"},{"ns":828,"exists":"","*":"Module:Sidebar"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"}],"images":["Ritalin-SR-20mg-1000x1000.jpg","Drug_Evaluation_Process.jpg"],"externallinks":["//doi.org/10.1002/9780470571224.pse420","http://www.cbsnews.com/news/4-americans-get-medical-pot-from-the-feds/","https://www.law.cornell.edu/cfr/text/21/312","http://www.fda.gov/cder/regulatory/applications/ind_page_1.htm","http://www.fda.gov/cder/guidance/959fnl.pdf","http://www.econlib.org/library/Enc1/DrugLag.html","https://www.worldcat.org/oclc/317650570","https://www.worldcat.org/oclc/50016270","https://www.worldcat.org/oclc/163149563","http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/InvestigationalNewDrugINDApplication/ucm071073.htm"],"sections":[{"toclevel":1,"level":"2","line":"Types","number":"1","index":"1","fromtitle":"Investigational_New_Drug","byteoffset":577,"anchor":"Types"},{"toclevel":1,"level":"2","line":"Application","number":"2","index":"2","fromtitle":"Investigational_New_Drug","byteoffset":2032,"anchor":"Application"},{"toclevel":1,"level":"2","line":"Miscellaneous","number":"3","index":"3","fromtitle":"Investigational_New_Drug","byteoffset":4234,"anchor":"Miscellaneous"},{"toclevel":1,"level":"2","line":"Examples","number":"4","index":"4","fromtitle":"Investigational_New_Drug","byteoffset":4537,"anchor":"Examples"},{"toclevel":1,"level":"2","line":"See also","number":"5","index":"5","fromtitle":"Investigational_New_Drug","byteoffset":5455,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"6","index":"6","fromtitle":"Investigational_New_Drug","byteoffset":5761,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"7","index":"7","fromtitle":"Investigational_New_Drug","byteoffset":5794,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Investigational New Drug","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q6060674"}]}}